The global mRNA vaccines and therapeutics market grew at a CAGR of around 8% during 2014-2019. Messenger Ribonucleic Acid (mRNA) refers to a single protein-coding gene in the genome that acts as a basis for protein synthesis within the cells. mRNA vaccines and therapeutics combine the desirable immunological properties and are prepared in laboratories using mammalian cells. Some of the common types of vaccines and therapeutics include self-amplifying, non-replicating, in vivo self-replicating and in vitro dendritic cell non-replicating mRNA. They are injected into the body to trigger virus-detecting immune sensors and produce viral antigen proteins within the cells. This aids in enhancing the body’s immunity by improving B- and T-cell responses.
The rising prevalence of medical ailments, such as diabetes, tuberculosis, cancer and cardiovascular diseases (CVDs), is one of the key factors driving the growth of the market. The increasing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections is also providing a boost to the market growth. In comparison to conventional medicines, mRNA vaccines and therapeutics are developed using advanced technologies that are more effective against pathogens, have higher potency, enhanced immunogenicity and are relatively more cost-effective. Additionally, improvements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are also creating a positive outlook for the market. Pharmaceutical companies are investing in mRNA technologies as they can combine multiple molecules into a therapeutic medicine, which is acting as another major growth-inducing factor. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with improvements in the healthcare technologies, are projected to drive the market further. Looking forward, IMARC Group expects the global mRNA vaccines and therapeutics market to witness moderate growth during the forecast period (2020-2025).
Breakup by Vaccine Type:
- Self-amplifying mRNA-based Vaccines
- Conventional Non-Amplifying mRNA-Based Vaccines
- Others
Breakup by Treatment Type:
- Bioengineered Vaccine Based Treatment
- Gene Therapy (Gene Silencing/Suppression)
- Gene Transcription (Protein Generation)
- Cell Therapy
- Monoclonal Antibody Based Treatment
- Others
Breakup by Vaccine Manufacturing:
- In-House mRNA Vaccine Manufacturing
- Out-Sourced mRNA Vaccine Manufacturing
Breakup by Application:
- Cancer
- Infectious Disease
- Vaccines In-vivo Therapeutics
- Gene Editing
- Others
Breakup by End-User:
- Hospitals and Clinics
- Research Organizations
- Others
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Argos Therapeutics Inc. (SCM Life Science and Genexine), AstraZeneca, Bayer AG, BioNTech AG, Boehringer Ingelheim, CRISPR Therapeutics, CureVac AG, eTheRNA Immunotherapies, Ethris GmbH, In-Cell-Art, Intellia Therapeutics Inc., Moderna Therapeutics, Sangamo Therapeutics, Tiba Biotech LLC, Translate Bio Inc., etc.
Key Questions Answered in This Report:
- How has the global mRNA vaccines and therapeutics market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the mRNA vaccines and therapeutics market?
- What is the breakup of the market based on the vaccine type?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the vaccine manufacturing?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global mRNA vaccines and therapeutics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Introduction to mRNA Vaccines and Therapeutics
5.1 History of mRNA Vaccines and Therapeutics Development
5.2 Incidence and Prevalence of Chronic Diseases and Major Infectious Diseases
5.3 Prevention and Treatment Using mRNA Vaccines and Therapeutics
5.3.1 mRNA Modifications
5.3.2 mRNA Efficiencies
5.3.3 Adjuvant/Stimulant and Carrier Technologies for mRNA-Based Vaccines
5.3.4 Carriers for mRNA-Based Protein and Antibody Therapeutics
6 Global mRNA Vaccines and Therapeutics Market
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Forecast
7 Market Breakup by Vaccine Type
7.1 Self-amplifying mRNA Based Vaccine
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Conventional Non-Amplifying mRNA-Based Vaccines
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Treatment Type
8.1 Bioengineered Vaccine Based Treatment
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Gene Therapy (Gene Silencing/Suppression)
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Gene Transcription (Protein Generation)
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cell Therapy
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Monoclonal Antibody Based Treatment
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Vaccine Manufacturing
9.1 In-House mRNA Vaccine Manufacturing
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Out-Sourced mRNA Vaccine Manufacturing
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Application
10.1 Cancer
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Infectious Disease
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Vaccines In-vivo Therapeutics
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Gene Editing
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by End-User
11.1 Hospitals and Clinics
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Research Organizations
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Others
11.3.1 Market Trends
11.3.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Argos Therapeutics Inc. (SCM Life Science and Genexine)
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 AstraZeneca
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Bayer AG
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 BioNTech AG
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 Boehringer Ingelheim
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 CRISPR Therapeutics
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 CureVac AG
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.8 eTheRNA Immunotherapies
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.9 Ethris GmbH
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 In-Cell-Art
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Intellia Therapeutics Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 Moderna Therapeutics
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.13 Sangamo Therapeutics
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
16.3.13.4 SWOT Analysis
16.3.14 Tiba Biotech LLC
16.3.14.1 Company Overview
16.3.14.2 Product Portfolio
16.3.15 Translate Bio Inc.
16.3.15.1 Company Overview
16.3.15.2 Product Portfolio
16.3.15.3 Financials
List of Figures
Figure 1: Global: mRNA Vaccines and Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: mRNA Vaccines and Therapeutics Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: mRNA Vaccines and Therapeutics Market: Breakup by Vaccine Type (in %), 2019
Figure 4: Global: mRNA Vaccines and Therapeutics Market: Breakup by Treatment Type (in %), 2019
Figure 5: Global: mRNA Vaccines and Therapeutics Market: Breakup by Vaccine Manufacturing (in %), 2019
Figure 6: Global: mRNA Vaccines and Therapeutics Market: Breakup by Application (in %), 2019
Figure 7: Global: mRNA Vaccines and Therapeutics Market: Breakup by End-User (in %), 2019
Figure 8: Global: mRNA Vaccines and Therapeutics Market: Breakup by Region (in %), 2019
Figure 9: Global: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 10: Global: mRNA Vaccines and Therapeutics (Self-amplifying mRNA-based Vaccine) Market: Sales Value (in Million US$), 2014 & 2019
Figure 11: Global: mRNA Vaccines and Therapeutics (Self-amplifying mRNA-based Vaccine) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 12: Global: mRNA Vaccines and Therapeutics (Conventional Non-amplifying mRNA-based Vaccine) Market: Sales Value (in Million US$), 2014 & 2019
Figure 13: Global: mRNA Vaccines and Therapeutics (Conventional Non-amplifying mRNA-based Vaccine) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 14: Global: mRNA Vaccines and Therapeutics (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 15: Global: mRNA Vaccines and Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 16: Global: mRNA Vaccines and Therapeutics (Bioengineered Vaccine Based Treatment) Market: Sales Value (in Million US$), 2014 & 2019
Figure 17: Global: mRNA Vaccines and Therapeutics (Bioengineered Vaccine Based Treatment) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 18: Global: mRNA Vaccines and Therapeutics (Gene Therapy) Market: Sales Value (in Million US$), 2014 & 2019
Figure 19: Global: mRNA Vaccines and Therapeutics (Gene Therapy) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 20: Global: mRNA Vaccines and Therapeutics (Gene Transcription) Market: Sales Value (in Million US$), 2014 & 2019
Figure 21: Global: mRNA Vaccines and Therapeutics (Gene Transcription) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 22: Global: mRNA Vaccines and Therapeutics (Cell Therapy) Market: Sales Value (in Million US$), 2014 & 2019
Figure 23: Global: mRNA Vaccines and Therapeutics (Cell Therapy) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 24: Global: mRNA Vaccines and Therapeutics (Monoclonal Antibody Based Treatment) Market: Sales Value (in Million US$), 2014 & 2019
Figure 25: Global: mRNA Vaccines and Therapeutics (Monoclonal Antibody Based Treatment) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 26: Global: mRNA Vaccines and Therapeutics (Others) Market: Sales Value (in Million US$), 2014 & 2019
Figure 27: Global: mRNA Vaccines and Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 28: Global: mRNA Vaccines and Therapeutics (In-House mRNA Vaccine Manufacturing) Market: Sales Value (in Million US$), 2014 & 2019
Figure 29: Global: mRNA Vaccines and Therapeutics (In-House mRNA Vaccine Manufacturing) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 30: Global: mRNA Vaccines and Therapeutics (Out-Sourced mRNA Vaccine Manufacturing) Market: Sales Value (in Million US$), 2014 & 2019
Figure 31: Global: mRNA Vaccines and Therapeutics (Out-Sourced mRNA Vaccine Manufacturing) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 32: Global: mRNA Vaccines and Therapeutics (Cancer) Market: Sales Value (in Million US$), 2014 & 2019
Figure 33: Global: mRNA Vaccines and Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 34: Global: mRNA Vaccines and Therapeutics (Infectious Disease) Market: Sales Value (in Million US$), 2014 & 2019
Figure 35: Global: mRNA Vaccines and Therapeutics (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 36: Global: mRNA Vaccines and Therapeutics (Vaccines In-vivo Therapeutics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 37: Global: mRNA Vaccines and Therapeutics (Vaccines In-vivo Therapeutics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 38: Global: mRNA Vaccines and Therapeutics (Gene Editing) Market: Sales Value (in Million US$), 2014 & 2019
Figure 39: Global: mRNA Vaccines and Therapeutics (Gene Editing) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 40: Global: mRNA Vaccines and Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
Figure 41: Global: mRNA Vaccines and Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 42: Global: mRNA Vaccines and Therapeutics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 43: Global: mRNA Vaccines and Therapeutics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 44: Global: mRNA Vaccines and Therapeutics (Research Organizations) Market: Sales Value (in Million US$), 2014 & 2019
Figure 45: Global: mRNA Vaccines and Therapeutics (Research Organizations) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 46: Global: mRNA Vaccines and Therapeutics (Other End-Users) Market: Sales Value (in Million US$), 2014 & 2019
Figure 47: Global: mRNA Vaccines and Therapeutics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 48: North America: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 49: North America: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 50: United States: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 51: United States: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 52: Canada: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 53: Canada: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 54: Asia Pacific: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 55: Asia Pacific: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 56: China: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 57: China: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 58: Japan: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 59: Japan: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 60: India: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 61: India: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 62: South Korea: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 63: South Korea: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 64: Australia: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 65: Australia: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 66: Indonesia: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 67: Indonesia: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 68: Others: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 69: Others: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 70: Europe: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 71: Europe: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 72: Germany: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 73: Germany: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 74: France: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 75: France: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 76: United Kingdom: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 77: United Kingdom: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 78: Italy: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 79: Italy: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 80: Spain: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 81: Spain: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 82: Russia: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 83: Russia: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 84: Others: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 85: Others: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 86: Latin America: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 87: Latin America: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 88: Brazil: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 89: Brazil: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 90: Mexico: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 91: Mexico: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 92: Others: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 93: Others: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 94: Middle East and Africa: mRNA Vaccines and Therapeutics Market: Sales Value (in Million US$), 2014 & 2019
Figure 95: Middle East and Africa: mRNA Vaccines and Therapeutics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 96: Global: mRNA Vaccines and Therapeutics Industry: SWOT Analysis
Figure 97: Global: mRNA Vaccines and Therapeutics Industry: Value Chain Analysis
Figure 98: Global: mRNA Vaccines and Therapeutics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: mRNA Vaccines and Therapeutics Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: mRNA Vaccines and Therapeutics Market Forecast: Breakup by Vaccine Type (in Million US$), 2020-2025
Table 3: Global: mRNA Vaccines and Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2020-2025
Table 4: Global: mRNA Vaccines and Therapeutics Market Forecast: Breakup by Vaccine Manufacturing (in Million US$), 2020-2025
Table 5: Global: mRNA Vaccines and Therapeutics Market Forecast: Breakup by Application (in Million US$), 2020-2025
Table 6: Global: mRNA Vaccines and Therapeutics Market Forecast: Breakup by End-User (in Million US$), 2020-2025
Table 7: Global: mRNA Vaccines and Therapeutics Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 8: Global: mRNA Vaccines and Therapeutics Market: Competitive Structure
Table 9: Global: mRNA Vaccines and Therapeutics Market: Key Players